Annual EBIT
-$51.84 M
+$16.09 M+23.69%
31 December 2023
Summary:
Verona Pharma annual earnings before interest & taxes is currently -$51.84 million, with the most recent change of +$16.09 million (+23.69%) on 31 December 2023. During the last 3 years, it has risen by +$13.13 million (+20.21%). VRNA annual EBIT is now -431883.33% below its all-time high of -$12.00 thousand, reached on 31 December 2005.VRNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$32.83 M
+$35.23 M+51.77%
30 September 2024
Summary:
Verona Pharma quarterly earnings before interest & taxes is currently -$32.83 million, with the most recent change of +$35.23 million (+51.77%) on 30 September 2024. Over the past year, it has dropped by -$18.59 million (-130.52%). VRNA quarterly EBIT is now -391.46% below its all-time high of $11.26 million, reached on 30 September 2021.VRNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$137.91 M
-$18.59 M-15.58%
30 September 2024
Summary:
Verona Pharma TTM earnings before interest & taxes is currently -$137.91 million, with the most recent change of -$18.59 million (-15.58%) on 30 September 2024. Over the past year, it has dropped by -$89.44 million (-184.53%). VRNA TTM EBIT is now -11068.61% below its all-time high of -$1.23 million, reached on 30 June 2016.VRNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.7% | -130.5% | -184.5% |
| 3 y3 years | +20.2% | -391.5% | -143.8% |
| 5 y5 years | -70.0% | -109.8% | -220.8% |
VRNA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.7% | -391.5% | +51.8% | -184.5% | at low |
| 5 y | 5 years | -70.0% | +23.7% | -391.5% | +51.8% | -254.0% | at low |
| alltime | all time | <-9999.0% | +23.7% | -391.5% | +51.8% | <-9999.0% | at low |
Verona Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.83 M(-51.8%) | -$137.91 M(+15.6%) |
| June 2024 | - | -$68.06 M(+190.2%) | -$119.32 M(+102.2%) |
| Mar 2024 | - | -$23.45 M(+72.9%) | -$59.02 M(+13.8%) |
| Dec 2023 | -$51.84 M(-23.7%) | -$13.56 M(-4.8%) | -$51.84 M(+7.0%) |
| Sept 2023 | - | -$14.24 M(+83.6%) | -$48.47 M(-2.5%) |
| June 2023 | - | -$7.76 M(-52.3%) | -$49.69 M(-16.5%) |
| Mar 2023 | - | -$16.28 M(+59.7%) | -$59.53 M(-12.4%) |
| Dec 2022 | -$67.93 M(+23.0%) | -$10.19 M(-34.1%) | -$67.93 M(-16.3%) |
| Sept 2022 | - | -$15.47 M(-12.1%) | -$81.16 M(+49.1%) |
| June 2022 | - | -$17.60 M(-28.7%) | -$54.43 M(-7.4%) |
| Mar 2022 | - | -$24.67 M(+5.3%) | -$58.79 M(+6.4%) |
| Dec 2021 | -$55.25 M(-15.0%) | -$23.43 M(-308.0%) | -$55.25 M(-2.3%) |
| Sept 2021 | - | $11.26 M(-151.3%) | -$56.57 M(-34.8%) |
| June 2021 | - | -$21.96 M(+3.9%) | -$86.72 M(+17.5%) |
| Mar 2021 | - | -$21.13 M(-14.7%) | -$73.79 M(+13.6%) |
| Dec 2020 | -$64.97 M(+60.5%) | -$24.75 M(+31.1%) | -$64.96 M(+54.0%) |
| Sept 2020 | - | -$18.89 M(+109.3%) | -$42.19 M(+8.3%) |
| June 2020 | - | -$9.02 M(-26.6%) | -$38.96 M(-11.3%) |
| Mar 2020 | - | -$12.29 M(+518.5%) | -$43.92 M(+8.9%) |
| Dec 2019 | -$40.49 M | -$1.99 M(-87.3%) | -$40.34 M(-6.2%) |
| Sept 2019 | - | -$15.65 M(+11.9%) | -$42.99 M(+35.1%) |
| June 2019 | - | -$13.98 M(+60.5%) | -$31.81 M(+73.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$8.72 M(+87.9%) | -$18.33 M(-42.9%) |
| Dec 2018 | -$30.49 M(-10.2%) | -$4.64 M(+3.7%) | -$32.08 M(-16.9%) |
| Sept 2018 | - | -$4.47 M(+779.2%) | -$38.60 M(-19.6%) |
| June 2018 | - | -$508.60 K(-97.7%) | -$48.00 M(-9.2%) |
| Mar 2018 | - | -$22.46 M(+101.3%) | -$52.87 M(+57.5%) |
| Dec 2017 | -$33.96 M(+367.6%) | -$11.16 M(-19.5%) | -$33.57 M(+36.8%) |
| Sept 2017 | - | -$13.86 M(+157.3%) | -$24.55 M(+84.3%) |
| June 2017 | - | -$5.39 M(+70.4%) | -$13.32 M(+45.3%) |
| Mar 2017 | - | -$3.16 M(+47.9%) | -$9.17 M(+52.6%) |
| Dec 2016 | -$7.26 M(-45.2%) | -$2.14 M(-18.8%) | -$6.01 M(+55.3%) |
| Sept 2016 | - | -$2.63 M(+113.2%) | -$3.87 M(+213.2%) |
| June 2016 | - | -$1.23 M | -$1.23 M |
| Dec 2015 | -$13.25 M(+124.4%) | - | - |
| Dec 2014 | -$5.90 M(+27.1%) | - | - |
| Dec 2013 | -$4.64 M(+11.2%) | - | - |
| Dec 2012 | -$4.18 M(+45.6%) | - | - |
| Dec 2011 | -$2.87 M(-1.2%) | - | - |
| Dec 2010 | -$2.90 M(+12.3%) | - | - |
| Dec 2009 | -$2.59 M(+19.0%) | - | - |
| Dec 2008 | -$2.17 M(-16.0%) | - | - |
| Dec 2007 | -$2.59 M(+97.0%) | - | - |
| Dec 2006 | -$1.31 M(>+9900.0%) | - | - |
| Dec 2005 | -$12.00 K | - | - |
FAQ
- What is Verona Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Verona Pharma?
- What is Verona Pharma annual EBIT year-on-year change?
- What is Verona Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Verona Pharma?
- What is Verona Pharma quarterly EBIT year-on-year change?
- What is Verona Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Verona Pharma?
- What is Verona Pharma TTM EBIT year-on-year change?
What is Verona Pharma annual earnings before interest & taxes?
The current annual EBIT of VRNA is -$51.84 M
What is the all time high annual EBIT for Verona Pharma?
Verona Pharma all-time high annual earnings before interest & taxes is -$12.00 K
What is Verona Pharma annual EBIT year-on-year change?
Over the past year, VRNA annual earnings before interest & taxes has changed by +$16.09 M (+23.69%)
What is Verona Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of VRNA is -$32.83 M
What is the all time high quarterly EBIT for Verona Pharma?
Verona Pharma all-time high quarterly earnings before interest & taxes is $11.26 M
What is Verona Pharma quarterly EBIT year-on-year change?
Over the past year, VRNA quarterly earnings before interest & taxes has changed by -$18.59 M (-130.52%)
What is Verona Pharma TTM earnings before interest & taxes?
The current TTM EBIT of VRNA is -$137.91 M
What is the all time high TTM EBIT for Verona Pharma?
Verona Pharma all-time high TTM earnings before interest & taxes is -$1.23 M
What is Verona Pharma TTM EBIT year-on-year change?
Over the past year, VRNA TTM earnings before interest & taxes has changed by -$89.44 M (-184.53%)